Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort studyArticle Published on 2024-01-052024-09-05 Journal: EClinicalMedicine [Category] update2024, [키워드] Acute kidney injury adverse outcome Critically ill children machine learning Prediction model SHAP [DOI] 10.1016/j.eclinm.2023.102409 PMC 바로가기 [Article Type] Article
In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective studyarticle Published on 2023-10-182024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] adverse outcome Chronic kidney disease COVID-19 omicron risk factor [DOI] 10.1186/s12879-023-08620-2 PMC 바로가기 [Article Type] article
Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19article Published on 2023-08-072024-09-05 Journal: BMC Geriatrics [Category] update2024, [키워드] adverse outcome COVID-19 Older adults SARS-CoV-2 statins [DOI] 10.1186/s12877-023-04183-8 PMC 바로가기 [Article Type] article
Is COVID-19 severity associated with telomere length? A systematic review and meta-analysisReview Paper Published on 2023-06-012024-09-05 Journal: Virus Genes [Category] update2024, [키워드] adverse outcome COVID-19 SARS-CoV-2 severity Telomere shortening [DOI] 10.1007/s11262-023-02010-1 PMC 바로가기 [Article Type] Review Paper
Serial measurements of lymphocytes, D-dimer, LDH, and CRP do not improve the ability to predict COVID-19 adverse outcomesRetrospective Clinical Research Report Published on 2023-05-122024-09-05 Journal: The Journal of international medical research [Category] update2024, [키워드] adverse outcome COVID-19 Mortality prediction retrospective cohort serum biomarker [DOI] 10.1177/03000605231173795 PMC 바로가기 [Article Type] Retrospective Clinical Research Report
Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysisReview Published on 2022-11-012023-07-10 Journal: International journal of colorectal disease [Category] COVID19(2023년), [키워드] adverse outcome IBD IBD drug Meta-analysis SARS-CoV-2 [DOI] 10.1007/s00384-022-04265-w PMC 바로가기 [Article Type] Review
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccinesArticle Published on 2022-10-112022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome adverse outcome Alpha Anti-RBD IgG BNT162b2 CD4 CD8 cell-mediated immune response cellular Clinical outcome comparable CoronaVac coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 vaccine COVID-19 vaccines diabete dose Effectiveness evaluated first dose healthy individual humoral immune response IgG antibody immune dysfunction Immunological memory immunological memory response Immunological response inactivated Infection influence initial memory mRNA neutralizing antibody neutralizing capacity of BNT162b2 Part Patient platform potential mechanism protective immunity RBD receiving Receptor binding domain reduction in resulting SARS-CoV2 second dose sera susceptibility T cell response T cells T2D Th1 titre Type type 2 diabete type 2 diabetes vaccination vaccinee Vaccines [DOI] 10.3389/fimmu.2022.1018393 PMC 바로가기
SARS-Cov-2 Infection in Severe Asthma Patients Treated With BiologicsArticle Published on 2022-10-012022-11-15 Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome administration Admission adverse outcome asked Asthma benralizumab biologic biologics characterized Cohort coronavirus coronavirus disease COVID-19 COVID-19 pandemic Deterioration died disease severity Exacerbation female General population Greece hospital infected patients Infection initial mechanical ventilation mepolizumab observé omalizumab outcome pandemic Patient patients treated physician polymerase chain provided required risk SARS-CoV-2 SARS-COV-2 infection Severe asthma severe COVID-19 severity systemic corticosteroids therapy treated Treatment was performed [DOI] 10.1016/j.jaip.2022.05.041 PMC 바로가기
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal ImpairmentArticle Published on 2022-10-012022-11-15 Journal: Clinical Pharmacology and Therapeutics [Category] 치료제, [키워드] 24 hour adjusted Administered adverse event adverse outcome assessments Chronic kidney disease clearance coronavirus disease COVID-19 decrease dose dose reduction Effect eliminated evaluated exhibited geometric geometric mean ratio glomerular filtration rate group increased risk kidney laboratory measurements Mild mild in severity moderate Nirmatrelvir oral participant Patient patients with moderate pharmacokinetics Phase I plasma plasma concentration positively correlated progression reducing renal renal function renal impairment risk Ritonavir severe disease severe renal impairment systemic Tolerability vital signs [DOI] 10.1002/cpt.2688 PMC 바로가기
Maternal mental health and breastfeeding amidst the Covid-19 pandemic: cross-sectional study in Catalonia (Spain)Article Published on 2022-09-262022-11-16 Journal: BMC Pregnancy and Childbirth [Category] SARS, 치료기술, [키워드] abnormality adverse outcome Affect age Anxiety bonding Breastfeeding carried conducted COVID-19 cross-sectional cut-off Depressive symptoms detect Edinburgh emotional enrolled First wave Follow-up health emergency hospital increase in infectious risk lactating lockdown Maternal Maternal mental health. mental health mother Neonatal Newborn outcome pandemic Postpartum pregnant women prospective observational study scale significant increase Spain step Study design women [DOI] 10.1186/s12884-022-05036-9 PMC 바로가기